ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 87 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $8,000 | -38.5% | 2,678 | -21.9% | 0.00% | -50.0% |
Q4 2019 | $13,000 | -35.0% | 3,427 | -13.3% | 0.00% | 0.0% |
Q3 2019 | $20,000 | -23.1% | 3,951 | -4.7% | 0.00% | -33.3% |
Q2 2019 | $26,000 | -23.5% | 4,148 | -14.2% | 0.00% | -62.5% |
Q1 2019 | $34,000 | -30.6% | 4,835 | -16.1% | 0.01% | -33.3% |
Q4 2018 | $49,000 | -39.5% | 5,765 | +43.2% | 0.01% | -25.0% |
Q3 2018 | $81,000 | -14.7% | 4,025 | +9.4% | 0.02% | -15.8% |
Q2 2018 | $95,000 | +13.1% | 3,680 | +5.0% | 0.02% | +5.6% |
Q1 2018 | $84,000 | -13.4% | 3,505 | +22.1% | 0.02% | -5.3% |
Q4 2017 | $97,000 | +79.6% | 2,870 | +12.5% | 0.02% | +90.0% |
Q3 2017 | $54,000 | – | 2,550 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |